skip to Main Content

News

Press Release: Istari Oncology Presents Data from Phase 1 Melanoma Study

For the full poster on the Phase 1 trial click the button below.

read more

Published Research in Nature Communications: Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity

Journal authors for the below study: Mubeen M. Mosaheb, Elena Y. Dobrikova, Michael C. Brown,…

read more

Published Research in Science Advances: CReP mediates selective translation initiation at the endoplasmic reticulum

Journal authors for the below study: Jonathan P. Kastan, Elena Y. Dobrikova, Jeffrey D. Bryant,…

read more

Announcing the new Istari Oncology website

Welcome to our new website; we invite you to look around. Please contact us if…

read more

Istari Oncology Announces NEJM Publication of Phase 1 Trial Results in Patients with Recurrent Glioblastoma Treated with PVSRIPO

21% Overall Survival at 24 Months and 36 Months, Compared to 14% and 4% in…

read more
Back To Top
×Close search
Search